baber/WOPTO huggingface dataset:
Patent SG-176682-A1 (SG)
Title: Channel switching processing method, system, and related devices
Inventor: XU YANGPO
IPC: H04N7/173
Filed: 2010-06-04
Abstract: A channel switching processing method, system, and related devices are provided. The method includes: receiving, by a switching server, a channel switching request sent by a receiving end; and when the switching server determines that current switching resource information does not meet aswitching condition according to the channel switching request, performing, by the switching server, an exception handling procedure, and sending channel switching instruction information to the receiving end, in which the channel switching instruction information is configured to instruct the receiving end to perform a channel switching operation corresponding to the channel switching instruction information. A channel switching processing system and related devices are alsoprovided. Therefore, the channel switching efficiency may be effectively improved.
Patent SG-176844-A1 (SG)
Title: Low concentration wastewater treatment system and process
Inventor: CONNER WILLIAM G
Filed: 2010-07-08
Abstract: A low concentration wastewater treatment system is provided that includes a high flux adsorbent material treatment system integrated with a low flux adsorbent material biological regeneration reactor. The high flux adsorbent material treatment system includes one or more unit operations for mixing low concentration wastewater with adsorbent material that is fresh, recycled, or a combination of both, and for decanting a liquid effluent having a reduced level of contaminants. The adsorbent material with adsorbed contaminants is regenerated in a low flux adsorbent material biological regeneration reactor in which a biological reaction occurs, such as biological oxidation, wherein organic contaminants in the wastewater are metabolized generally into carbon dioxide and water. Excess biomass is removed from the adsorbent material, and the thus- regenerated adsorbent material is recycled to the high flux adsorbent material treatment system.
Patent SG-177916-A1 (SG)
Title: Permanent magnet and method of manufacturing same
Inventor: NAGATA HIROSHI
Filed: 2007-12-19
Abstract: PERMANENT MAGNET AND METHOD OF MANUFACTURING SAMEDisclosed is a method for producing a permanent magnet, which enables to disperse Dy and/or Tb, which adherers to the surface of a sintered magnet containing a lubricant, into the crystal grain boundary phase of the sintered magnet, thereby producing a permanent magnet having high magnetic characteristics with high productivity. Specifically, there are performed a first step for adhering at least one of Dy and Tb to at least a part of the surface of a sintered magnet obtained by sintering an iron-boron-rare earth alloy material powder containing a lubricant, and a second step for dispersing at least one of Dy and Tb adhering to the surface of the sintered magnet into the crystal grain boundary phase of the sintered magnet by conducting a heat treatment at a certain temperature. In this connection, one having an average crystal grain size within the range of 4-8 pm is used as the sintered magnet.Figure 2
Patent SG-177944-A1 (SG)
Title: Methods for the treatment of autoimmune disorders using immunosuppressive monoclonal antibodies with reduced toxicity
Inventor: KOENIG SCOTT
Filed: 2006-07-11
Abstract: The present invention provides methods of treating, preventing or ameliorating the symptoms of T cell-mediated immunological diseases, particularly autoimmune diseases, through the use of anti-CD3 antibodies. In particular, the methods of theinvention provide for administration of antibodies that specifically bind the epsilon subunit within the human CD3 complex. Such antibodies modulate the T cell receptor/alloantigen interaction and, thus, regulate the T cell mediated cytotoxicity associated with autoimmune disorders. Additionally, the invention provides for modification of the anti-CD3 antibodies such that they exhibit reduced or eliminatedeffector function and T cell activation as compared to non- modified anti-CD3 antibodies. Figure No. lA
Patent SG-178997-A1 (SG)
Title: Substituted dihydro benzocycloalkyloxymethyl oxazolopyrimidinones, preparation and use thereof
Inventor: KOSLEY RAYMOND WALTER JR
Filed: 2010-09-14
Abstract: The present invention relates to a series of substituted dihydro benzocycloalkyl-oxymethyl oxazolopyrimidinones of formula (I) as defined herein. This invention also relates to methods of making these compounds including novel intermediates. The compounds of this invention are modulators of metabotropic glutamate receptors (mGluR), particularly, mGluR2 receptor. Therefore, the compounds of this invention are useful as pharmaceutical agents, especially in the treatment and/or prevention of a variety of central nervous system disorders (CNS), including but not limited to acute and chronic neurodegenerative conditions, psychoses, cognition deficit disorders, convulsions, anxiety, depression, migraine, pain, sleep disorders and emesis.
Patent SG-181105-A1 (SG)
Title: Instrument for independent electrotransfer in multiple cassettes
Inventor: LATHAM MATTHEW
Filed: 2010-12-09
Abstract: Electrotransfer is performed in an instrument that receives electroblotting cassettes and that contains an integrated power supply, controls, and a display that allows the user to monitor and control each of a plurality of cassettes individually through electrical contacts within the housing that mate with corresponding electrical contacts on the cassettes.
Patent SG-182151-A1 (SG)
Title: Polypeptides, antibody variable domains and antagonists
Inventor: JESPERS LAURENT
Filed: 2008-06-04
Abstract: The invention relates to anti-IL-1R1 polypeptides and antibody single variable domains (dAbs) that are resistant to degradation by a protease, as well as antagonists comprising these. The polypeptides, dAbs and antagonists are useful for as therapeutics and/or prophylactics that are likely to encounter proteases when administered to a patient, for example for pulmonary administration, oral administration, delivery to the lung and delivery to the GI tract of a patient, as well as for treating inflammatory disease, such as arthritis or COPD.Fig. 2
Patent SG-182661-A1 (SG)
Title: 7 - (alk- 1 ' -enyl) - 2h-benzo [b] [1, 4] dioxepin- 3 (4h) - ones and their use in fragrance applications
Inventor: KRAFT PHILIP
Filed: 2011-02-09
Abstract: A compound of the formula (I) in which R1 is H or methyl, R2 is H, methyl or ethyl, R3 and R4 are independently hydrogen, methyl, ethyl, n-propyl or iso-propyl, and the dashed lines representing the alternative possibilities of there being present either an additional double bond or an additional group R5, which is H or methyl. The compounds possess a marine odour with sweet character, and are useful in fine and functional fragrances.
Patent SG-187056-A1 (SG)
Title: Method and apparatus for determining a temperature of a vibrating sensor component of a vibrating meter
Inventor: MANSFIELD WILLIAM M
Filed: 2010-08-02
Abstract: A method for determining a temperature of a vibrating sensor component (204A, 205A, 205'A) coupled to a conduit (203A, 203B) of a vibrating meter (200) is provided. The method comprises a step of supplying the vibrating sensor component (204A, 205A, 205'A) with a temperature determination signal (313). The method also comprises a step of measuring a resulting signal (314). The method further comprises a step of determining a temperature of the sensor component (204A, 205A, 205'A) based on the temperature determination signal (313) and the resulting signal (314).
Patent SG-192883-A1 (SG)
Title: Inventory pooling for multiple merchants
Inventor: BROWN MICHAEL G
Filed: 2012-03-05
Abstract: Disclosed are various embodiments for implementing inventory pooling for multiple merchants. A first inventory of an item held at a first fulfillment center on behalf of a first merchant is contributed to a common pool of inventory. A second inventory of the item held at a second fulfillment center on behalf of a second merchant is contributed to the common pool of inventory. Fulfillment of an order placed by a customer of the first merchant is initiated from the second inventory of the item that was contributed by the second merchant to the common pool of inventory.
Patent SG-193285-A1 (SG)
Title: Dose setting mechanism and injection device
Inventor: PLUMPTRE DAVID AUBREY
Filed: 2012-03-22
Abstract: A dose setting mechanism (1) for a resettable drug delivery device is provided comprising a dose setting member (3) and a drive member (4) for driving a piston rod in a distal direction during dose dispensing, wherein the drive member (4) comprises a proximal drive member (4'') and a distal drive member (4'). Further, a first clutch is provided for releasably coupling the proximal drive member (4'') and the distal drive member (4'). A spring means (7) biases the proximal drive member (4'') and the distal drive member (4') in the coupled state during dose setting and dose dispensing. According to one aspect of the invention engaging means (3a, 4a) are provided associated to the proximal drive member (4'') and to the dose setting member (3), wherein the engaging means (3a, 4a) are designed and arranged such that the proximal drive member (4'') entrains the dose setting member (3) in the distal direction during dose setting but allows a relative axial movement of the proximal drive member (4'') with respect to the dose setting member (3) in the proximal direction. Further, the invention refers to an injection device with such a dose setting mechanism.
Patent SG-193488-A1 (SG)
Title: Elevator having a minimal elevator shaft well depth and a permanent protective space
Inventor: HENSELER MARKUS
Filed: 2012-03-21
Abstract: HSP001512AbstractThis lift has, when the lift cage is in its lowermost access level, no lift shaft pit or one with absolute minimal lift shaft pit depth. Nevertheless, the regulations of the Lift Ordinance with respect to free spaces against the risk of being crushed are fulfilled. The lift cage (6) is for this purpose movable in a lift shaft (17) with shaft doors (11-14) to several access levels (1-4). Maintenance operations can be carried out both on the lift cage (6) or from the interior of the lift cage (6). As a feature, access to the region (17) below the lift cage (6) is made impossible. The solution for that purpose consists in that at least the lowermost shaft door (11) is permanently locked, whilst all upper shaft doors (12-14) can have emergency unlocking means. The at least lowermost shaft door (11) is thus permanently locked, with the exception of the state in which the lift cage (6) is in stopped state, or is stopped, opposite it. The required permanent protective space F consists of the entire interior of the lift cage (6) itself. (Figure 1)
Patent WO-2016122400-A1 (WO)
Inventor: ATHAUDA THARINDU
IPC: A41D27/08
Filed: 2015-12-30
Abstract: Disclosed herein is a visibility-enhancing device (100) that requires the presence of a textile or fabric (110) having an internal surface and an external surface; and a flexible and conformable visible light source apparatus attached to the textile or fabric, wherein the visible light source apparatus comprises: at least one visible light source (130) that is positioned towards the internal surface of the textile or fabric and/or is positioned to provide light at an angle that is substantially perpendicular to the internal surface of the textile or fabric; at least two conductive members (140) having a first end (141) and a second end (142), where the first end is connected to the at least one visible light source and the second end is adapted to connect to a power source (150); and at least one transparent polymer layer (160) that encapsulates the entirety of the at least one visible light source and at least part of the at least two conductive members.
Patent WO-2019035766-A1 (WO)
Title: A label-free method and system for measuring drug response kinetics of three-dimensional cellular structures
Inventor: KOH LIE YONG JUDICE
IPC: G01N33/48
Filed: 2018-08-14
Abstract: Disclosed herein are methods of providing a computational model for predicting an activity of a test agent with respect to a 3D cell structure, such as spheroid, organoid and tumorsphere. Specifically, machine learning algorithm is employed to generate a quantitative model of drug response in the 3D cell structure using zone-specific image features, wherein the zones comprise a necrotic zone, a quiescent zone, and a proliferating zone. Also disclosed herein are label-free prediction methods using such computational model and a device configured to perform the methods as disclosed herein.
Patent WO-2021118455-A1 (WO)
Inventor: KANDEGEDARA DEEYAYAWATHTHE GEDARA RUMESH MAHELA
IPC: A61F13/14
Filed: 2020-09-07
Abstract: The present invention generally relates to an absorbent component (100) for use in a garment. The absorbent component (100) comprises: a first layer composite (120) comprising a first foam layer (122) and a first liquid impermeable layer (124); an absorbent layer composite (140) bonded to the first liquid impermeable layer (124) for absorbing bodily fluids; and a second liquid impermeable layer (164) bonded to the absorbent layer composite (140) and first layer composite (120) to contain the bodily fluids absorbed by the absorbent layer composite (140), wherein the second liquid impermeable layer (164) forms an opening (166) for receiving the bodily fluids to the absorbent layer composite (140); and wherein the first foam layer (122) is moulded to shape the absorbent component (100).
Patent WO-2022075920-A1 (WO)
Title: Réseautage social utilisant la réalité augmentée
Inventor: LI YUNJIU
IPC: G06T19/00
Filed: 2021-09-20
Abstract: L'invention concerne des systèmes et des procédés pour un réseautage social utilisant la réalité augmentée. Un réseau peut recevoir, en provenance d'une pluralité de dispositifs clients, une demande de connexion à un serveur. Le serveur peut être associé à un objet, tel qu'un point de repère ou un produit. Le serveur peut sérialiser un monde en RA comportant l'objet et le contenu associé à l'objet et envoyer, à la pluralité de dispositifs clients, des données représentant le monde en RA. Le serveur, par l'intermédiaire d'un réseau, peut recevoir, en provenance d'un premier dispositif client parmi la pluralité de dispositifs clients, une indication d'entrée d'utilisateur associée au monde en RA. L'indication d'entrée d'utilisateur peut comprendre des données de texte, des données d'image numérique ou une rétroaction d'utilisateur. L'indication de l'entrée d'utilisateur peut être diffusée à la pluralité de dispositifs clients.
Patent WO-2011105969-A1 (WO)
Title: Dispositif de ventilation
Inventor: NOVAK PETER
IPC: F24F12/00
Filed: 2011-02-23
Abstract: L'invention est conçue pour les besoins réels d'un dispositif de ventilation suffisamment efficace, qui permettra d'une part d'être réduit à un minimum dans la mesure où, pendant la première installation ou pendant le remplacement de fenêtres en cas de rénovation de bâtiments, il peut soit être installé dans le cadre de fenêtre (91), soit éventuellement monté dans la paroi du bâtiment directement près de ce cadre (91), et contribuera d'autre part efficacement à l'amélioration sensible du bilan énergétique du bâtiment respectivement ventilé. En général, ce type de dispositif de ventilation comprend un logement (1) doté d'un échangeur thermique à contre-courant comprenant une partie primaire reliée à une admission externe (11) pour l'alimentation en air dans le logement (1) et à une admission interne (13) conçue pour l'alimentation en air depuis le dispositif dans la chambre respectivement ventilée, et une partie secondaire reliée à une évacuation interne (14) pour l'évacuation d'air depuis la pièce dans le dispositif et également à une évacuation externe (12) pour l'évacuation d'air depuis le dispositif dans les alentours du bâtiment respectivement ventilé.
Patent TN-2009000323-A1 (TN)
Title: Modulators of sclerostin binding partners for treating bone-related disorders
Inventor: LU CHRIS XIANGYANG
IPC: A61P19/10
Filed: 2009-07-31
Abstract: The present invention relates to the use of modulators of the sclerostin: sclerostin- binding-partner interaction for the treatment, amelioration, and diagnosis of sclerostin-related disorders, e.g., osteoporosis and sclerosteosis, and sclerostin-related disorders, e.g., cancers and cardiovascular disorders. The invention also relates to the use of sclerostin-binding-partner mimetics for the treatment, amelioration, and diagnosis of sclerostin-related disorders. Assays for the identification of modulators of the sclerostin: sclerostin-binding-partner interaction, as well as the resulting signaling, are also provided.
Patent TN-2012000554-A1 (TN)
Title: Module pour absorbeur thermique de recepteur solaire, absorbeur comportant au moins un tel module et recepteur comportant au moins un tel absorbeur
Inventor: FOURMIGUE JEAN-FRAN?OIS
IPC: F24S10/50
Filed: 2012-11-23
Abstract: Absorbeur (6) pour récepteur solaire comportant un boîtier (12) d'axe longitudinal (X) comprenant à une première extrémité longitudinale (18.1) un collecteur d'alimentation (20) en fluide caloporteur à une deuxième extrémité longitudinale (18.2) un collecteur d'évacuation (22) dudit fluide, le boîtier comportant une première paroi (14.1) munie d'une face (6.1) destinée à être soumise à un flux lumineux (F), une deuxième paroi (14.2) en regard de la première paroi, des parois latérales (16.1, 16.2) reliant lesdites première (14.1) et deuxième (14.2) parois, ledit boîtier (12) comportant des moyens (28) reliant rigidement la première et la deuxième paroi, formé par au moins une nervure (30) s'étendant longitudinalement fixée à la première (14.1) et à la deuxième (14.2) paroi, ladite nervure (30) comportant des fenêtres (32) et des déflecteurs (34) associés aux fenêtres (32), lesdits déflecteurs (34) imposant à une partie du fluide d'emprunter lesdites fenêtres (32) provoquant un remélange du fluide.
Patent TN-2013000015-A1 (TN)
Title: Dry powder formulation comprising a phosphodiesterase inhibitor
Inventor: COCCONI DANIELA
IPC: A61P11/06
Filed: 2013-01-22
Abstract: The invention relates to a pharmaceutical formulation in the form of inhalable dry powder comprising particles of a phosphodiesterase-4 inhibitor as active ingredient. The invention also relates to the process for the preparation thereof, and to its use in the prevention and/or treatment of a respiratory disease such as asthma and COPD
Patent TN-2014000028-A1 (TN)
Title: Device for automatic injection of drug doses
Inventor: EDHOUSE MARK JEFFREY
IPC: A61M5/32
Filed: 2014-01-20
Abstract: A device for the automatic injection of doses of a drug compound comprising a sliding sheath (30) which, when depressed with its front end (3) against the injection site, interacts with cam means (26, 27, 28) to activate the triggering of a plunger (8), controlling the delivery of a drug dose. Plunger guide means (44) are provide for controlling the triggering sequence and means (4) for arming the device in the dose delivery condition. Automatic needle re-sheathing and resetting of a lock-out condition after each dose is delivered are provided. The number of the device components is reduced resulting in a simpler structure and cost reduction.
Patent TN-2017000357-A1 (TN)
Title: Substituted nucleoside derivatives useful as anticancer agents
Inventor: KUMPF ROBERT ARNOLD
IPC: C07H19/24
Filed: 2016-02-15
Abstract: Compounds of the general Formula (I): processes for the preparation of these compounds, compositions containing these compounds, and the uses of these compounds.
Patent TN-2020000019-A1 (TN)
Title: Lego Blocks
Inventor: GHADIRI FAOUZI
IPC: E04C1/40
Filed: 2020-02-03
Abstract: Cette invention s'agit tout simplement de créer une nouvelle forme et façon de fabrication de brique ou bloc de béton ou 'Galeb' ou n'importe quel autre moyen de construction qui remplace les briques d'une manière qui rend la construction d'un bâtiment plus facile, plus rapide, moins cher et écologique. Ceci avec le principe des entrées et sorties mâles et femelles dans les briques qui seront très bien attachés des quatre cotés (haut, bas, droite et gauche) et ceci même sans ciment pour les attacher l'une à l'autre.
Patent WO-2016114725-A1 (WO)
Inventor: ŐNCEL HATICE
IPC: A61K31/00
Filed: 2015-01-12
Abstract: La présente invention concerne une composition de comprimé pharmaceutique bicouche stable comprenant de l'irbésartan, un antagoniste des récepteurs de l'angiotensine II, présentant une taille des particules d90 inférieure à 30 microns, et du bésilate d'amlodipine, un inhibiteur du canal calcique, dans différentes couches. La présente invention concerne en outre un procédé de fabrication dudit comprimé bicouche.
Patent TR-2021004882-A1 (TR)
Title: Kavi̇te-i̇çi̇ lazer-tabanli gli̇koz metre
Inventor: İSMAİL BAYRAKLI
IPC: G01N21/17
Filed: 2021-03-16
Abstract: Bu buluş, diyabet hastalığının teşhisi ve takibi için girişimsel olmayan, iğnesiz lazer tabanlı glikoz metre ile ilgili olup, özelliği; soğurma yoluyla akustik dalga oluşumunu sağlayan ışık kaynağı ve modülatör (1), ışının ıraksayarak yayılımını sağlayan kazanç çipi (3), kazanç çipinden (3) gelen ışını paralel doğrultuya getiren mercek (4), mercekten (4) gelen ışının soğurulması yoluyla soğurma çizgilerinin ve akustik dalgaların oluşmasını sağlayan soğurma hücresi (5), soğurma hücresinden (5) gelen ışını kırınıma uğratan optik kırınım ağı (6), optik kırınım ağından (6) gelen ışını yansıtma görevi gören ayna (7), ışının dalga boyunun ölçülmesini sağlayan FPI girişimölçer (8), tespit edilen ışının elektrik sinyalini dönüşümünü sağlayan detektör (9) ve sinyalin işlenip görüntülenmesini sağlayan bilgisayar ve yazılıma (10) sahip olmasıdır.
Patent WO-2021257029-A1 (WO)
Title: A uracil compounds with anticancer activity
Inventor: KOZ GAMZE
IPC: A61K31/505
Filed: 2021-06-09
Abstract: The present invention is related to a group of small organic molecules that possess arylidene uracil moiety and exhibit anticancer activity. More particularly, the present invention is related to arylidene uracil compounds, which have a potential to show a better anticancer activity with lower concentrations than present compounds in cancer treatment, thus causing less damage to healthy cells and less side effects (nausea, hair loss, anemia, etc.).
Patent WO-2022182309-A1 (WO)
Title: Procédé de synthèse pour un nouvel agent de blanchiment
Inventor: UGRAS HALIL IBRAHIM
IPC: C07C409/30
Filed: 2021-12-30
Abstract: La présente invention concerne un procédé de synthèse d'un agent de blanchiment organique, en particulier pour le blanchiment de denims dans le secteur textile. Plus particulièrement, l'invention concerne un nouveau procédé de synthèse de l'acide peroxycarbonique et de sels de celui-ci, le procédé fournissant un produit avec un rendement élevé au moyen d'un processus sans eau dans lequel une faible quantité de solvants est utilisée. L'invention comprend deux procédés de synthèse différents : des procédés in situ et des procédés effectués dans un réacteur.
Patent WO-2023048672-A1 (WO)
Inventor: COŞKUNÜZER ABDULLAH
IPC: B26D1/02
Filed: 2022-06-30
Abstract: The invention relates to a trimming device (A) that has a printing surface for bonding plastic-, or wood-based edgebandings to a particle board, and is developed for cutting (trimming) the excess chips remaining on the edge and corner parts of the particle board after the bonding process.
Patent WO-2023211403-A1 (WO)
Inventor: TANGÜLER HASAN
IPC: A23L23/10
Filed: 2022-12-01
Abstract: The invention relates to the method of separating the bulgur flour, which is used in the production of shalgam beverages and which becomes a waste as a result of production, after removing the drinkable shalgam beverage. Bulgur flour powder is related to the use of waste fermented bulgur flour in a freeze-drying machine to produce a high-value-added product by turning it into powder after drying.